Revisional Augmentation
infection, hematoma, rupture, implant-related reoperations
BREAST CANCER, INFECTION, SCARRING, HEMATOMA, COMPLICATIONS
The Kaplan-Meier estimate for any reoperation was 8.6%, with implant-related reoperations at 2.8%. The most frequent complications in this cohort were a new diagnosis of non–breast cancer (4.5%), explantation with or without replacement (4.3%, with 2.9% being replaced with a study device), Baker Grade III/IV capsular contracture (3.0%), patient dissatisfaction with appearance (1.5%), nonhypertrophic scarring (1.5%), and hematoma (1.3%). No other complications, including rupture, infection, implant malposition/displacement, and wrinkling/rippling, were reported through 3 years of follow-up.